NIH-funded research R01 grant

Understanding genetic mutations that cause allergic diseases in children

Official title: Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease

Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-10881991 · Data updated 2026-11-12

This study is looking at how certain genetic changes can affect the immune system in kids with allergies and conditions like asthma and eczema, and it hopes to find new ways to help manage these issues, possibly using a substance called glutamine.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med
NIH-funded
Lab location1 site (Bethesda, United States)
Project startJuly 5, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$708,492
NIH project number5R01AI168295-02
Project IDNIH-10881991 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are children aged 0-11 years who have been diagnosed with atopic diseases such as asthma, eczema, or food allergies.

Less likely to help

Patients with non-allergic conditions or those outside the age range of 0-11 years may not benefit from this research.

What this research studies

This research investigates how specific genetic mutations in the CBM complex affect the immune system, particularly in children with atopic diseases like asthma and eczema. By studying the signaling processes disrupted by these mutations, researchers aim to understand how they lead to abnormal immune responses and allergic reactions. The project will also explore potential treatment strategies, including the use of glutamine, to help manage these conditions. Patients with severe allergies and immune disorders may be directly involved in this research to better understand their conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for children suffering from severe allergic diseases.

How similar studies have gone: Previous research has shown promising results in understanding immune disorders linked to genetic mutations, indicating a potential for success in this area.

Where this research is happening

  • Henry M. Jackson Fdn for the Adv Mil/med
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Snow, Andrew L — Henry M. Jackson Fdn for the Adv Mil/med
  • Study coordinator: Snow, Andrew L

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.